129 related articles for article (PubMed ID: 33426619)
1. Determination and Comparison of the Solubility, Oil-Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol Enantiomers.
Zhang Q; Wang X; Xue H; Huang B; Lin Z; Cai Z
AAPS PharmSciTech; 2021 Jan; 22(1):43. PubMed ID: 33426619
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective metabolism of carvedilol in the rat. Use of enantiomerically radiolabeled pseudoracemates.
Fujimaki M; Shintani S; Hakusui H
Drug Metab Dispos; 1991; 19(4):749-53. PubMed ID: 1680650
[TBL] [Abstract][Full Text] [Related]
3. Optimization of lipid materials in the formulation of S-carvedilol self-microemulsifying drug-delivery systems.
Zhang Q; Guo K; Wang X; Huang B; Lin Z; Cai Z
Drug Dev Ind Pharm; 2020 Sep; 46(9):1507-1516. PubMed ID: 32806972
[TBL] [Abstract][Full Text] [Related]
4. Identification of two major biliary metabolites of carvedilol in rats.
Fujimaki M; Hakusui H
Xenobiotica; 1990 Oct; 20(10):1025-34. PubMed ID: 2082592
[TBL] [Abstract][Full Text] [Related]
5. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
6. Preparation, Characterization, and Selection of Optimal Forms of (S)-Carvedilol Salts for the Development of Extended-Release Formulation.
Zhang Q; Huang B; Xue H; Lin Z; Zhao J; Cai Z
Mol Pharm; 2021 Jun; 18(6):2298-2310. PubMed ID: 34032449
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
Fujimaki M
Drug Metab Dispos; 1994; 22(5):700-8. PubMed ID: 7835220
[TBL] [Abstract][Full Text] [Related]
8. Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction.
Neugebauer G; Gabor M; Reiff K
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S142-6. PubMed ID: 1378143
[TBL] [Abstract][Full Text] [Related]
9. Renal, biliary and intestinal clearance of sotalol enantiomers in rat model: evidence of intestinal exsorption.
Carr RA; Pasutto FM; Foster RT
Biopharm Drug Dispos; 1996 Nov; 17(8):725-35. PubMed ID: 8950050
[TBL] [Abstract][Full Text] [Related]
10. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
11. Poor and enantioselective bioavailability of naftopidil enantiomers is due to extensive and stereoselective metabolism in rat liver.
Liu X; Zhu L; Huang B; Huang J; Cai Y; Zhu L; Wu B; Fu X; Zhang X; Rong Y; Xiao Q; Guo J; Li A; Guo Y; Yuan M
J Pharm Biomed Anal; 2017 Jan; 132():165-172. PubMed ID: 27744175
[TBL] [Abstract][Full Text] [Related]
12. pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.
Hamed R; Awadallah A; Sunoqrot S; Tarawneh O; Nazzal S; AlBaraghthi T; Al Sayyad J; Abbas A
AAPS PharmSciTech; 2016 Apr; 17(2):418-26. PubMed ID: 26202065
[TBL] [Abstract][Full Text] [Related]
13. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
[TBL] [Abstract][Full Text] [Related]
14. Enhancement effect of geniposide on solubility and intestinal absorption of baicalin.
Jin M; Zhang T; Ding Y; Huang T; Cai Z
Pak J Pharm Sci; 2019 Sep; 32(5):1933-1940. PubMed ID: 31813855
[TBL] [Abstract][Full Text] [Related]
15. Saturable enantioselective first-pass effect for carvedilol after high oral racemate doses in rats.
Stahl E; Henke D; Mutschler E; Spahn-Langguth H
Arch Pharm (Weinheim); 1993 Mar; 326(3):123-5. PubMed ID: 8097624
[TBL] [Abstract][Full Text] [Related]
16. [Polybasic research on the biopharmaceutical characteristics of 20 (S)-protopanaxadiol].
Jin X; Zhang ZH; Sun E; Tan XB; Xia HJ; Liu QY; Jia XB
Yao Xue Xue Bao; 2013 Mar; 48(3):411-6. PubMed ID: 23724657
[TBL] [Abstract][Full Text] [Related]
17. Moment analysis of stereoselective biliary excretion and chiral inversion of ketoprofen enantiomers in perfused rat liver.
Yasui H; Yamaoka K; Dote N; Nakagawa T
J Pharm Sci; 1995 Nov; 84(11):1327-31. PubMed ID: 8587051
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and physiology of the biliary radiographic contrast materials.
Berk RN; Loeb PM
Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
[TBL] [Abstract][Full Text] [Related]
20. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism.
Fujimaki M; Murakoshi Y; Hakusui H
J Pharm Sci; 1990 Jul; 79(7):568-72. PubMed ID: 1975840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
